![](/wp-content/themes/basic-child/images/print.png)
Protected: Reimbursement Form: Scholarship Attendance Lyme & Other Tick-Borne Diseases 2023 Conference
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
Thank you everyone for attending. Link to the CME Survey Form ATTENTION: Message from the LDA President on Recordings – Major Zoom Failure I am happy to report that the […]
There is no excerpt because this is a protected post.
Virtual: Friday, October 13, 2023 & Saturday, October 14, 2023. DON’T MISS OUT, REGISTER TODAY! Conference Recording: Available to view through Oct. 22, 2023 for those registrants who register by conference time. STILL AVAILABLE: MEDICAL CATEGORY SCHOLARSHIPS. A few scholarships are still available for medical students, researchers, recent medical professionals, and health department representatives. Apply today!
Journal of the Pediatric Infectious Diseases Society (Thompson, A.D., et al) 09.26.2023 published, “Sensitivity of Two-Tiered Lyme Disease Serology in Children with an Erythema Migrans Lesion.” Results of this study showed that sensitivity of serologic detection of Lyme disease was higher in children that presented with multiple erythema migrans (EM) lesions, than those with a single lesion.
The British Pharmacological Society Journals (Clark, IA and Vissel, B.) 09.26.2023, published “Autocrine positive feedback of tumor necrosis factor from activated microglia proposed to be of widespread relevance in chronic neurological disease.” In this study, researchers suggest that persistence of tumor necrosis factor (TNF) through a “positive feedback loop” of this cytokine is involved in chronic central nervous system (CNS) illnesses.
The Journal of Clinical Microbiology (Drews, S.J.; et al.) 09.26.2023 published, “Transfusion-transmitted Babesia spp.: a changing landscape of epidemiology, regulation, and risk mitigation.” In this mini review, authors describe the epidemiology of Babesia for humans, vectors, and pathogen hosts as impacts of climate change influence occurrence and risks associated with this pathogen.
The DailyMail.com (Luke Andrews) 09.26.2023, has reported in an exclusive news article “Experimental Lyme disease pill laces your skin with poison – killing parasites before they infect.” Tarsus Pharmaceuticals, a California-based company has developed an experimental drug that will kill ticks that bite human skin.
Courthouse News Service (Cameron Langford) 09.07.2023, published an update on the 5th Circuit court case dealing with claims of patients against the Infectious Diseases Society of America (IDSA). In 2017, […]
Mount Sinai website, 09.20.2023, published a press release “Mount Sinai Receives $6.2 Million Grant from the Steven & Alexandra Cohen Foundation for the Clinical Care of Long Lyme Disease.” Mount […]
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.
Some providers may not specifically treat Lyme and TBD but see patients who have symptoms associated with Lyme and TBD to address those specific symptoms. Contact the provider to confirm.
It is your responsibility to contact the provider’s office to confirm the current address, directions, nature of services provided, and all other provider information before you make an appointment.
DISCLAIMER: The Lyme Disease Association, Inc. provides referrals to health care providers who treat Lyme disease, and often other TBD, as a courtesy to those seeking Lyme Literate Physicians (LLMD). However, some of the providers included do not specifically treat Lyme and TBD but see patients who have symptoms associated with Lyme and TBD to address those specific symptoms. We do not evaluate the professional competence or qualifications of health care providers on our referral list or the costs of services provided. Accordingly, the LDA neither warrants nor endorses the health care providers contained on this list nor the quality of care you will receive from those providers. We do not make recommendations, only referrals. LDA does not receive any monies from physicians to be included on this list nor does LDA provide any monies to physicians. Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines: Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the Doctor Referral System contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the zip code entered and category/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of.
LDA does not accept or reply to any comments on:
We cannot guarantee that the information provided will be timely and accurate or that physicians on the list are accepting new patients, or that they accept insurance. The selection of a physician should be made by you after careful consideration. There are two approaches in the treatment of Lyme disease. Our list contains physicians who generally follow more flexible treatment approaches than those advocated by the Infectious Diseases Society of America (IDSA). LDA is not responsible for incorrect information on the website. BEFORE DOCTOR VISIT: Please contact the physicians’ offices directly to confirm their current address, directions, and any other necessary information before scheduling an appointment. Do not rely only on the maps provided on this site. The maps on LDA’s Doctor Referral System are for informational purposes and provide an approximate locality of the listing based on the addresses we are provided with at the time of site updates. Practitioners often relocate and addresses can change. Notification of changes in listed information can be updated on our Dr. Referral Contact Form. Thank you, Lyme Disease Association, Inc. (LDA)
Subscriber information will not be shared outside of the Lyme Disease Association, Inc. nor used for donor solicitation.
The Lyme Disease Association, Inc. reserves the right to unsubscribe anyone from this service without cause.